We have demonstrated that COS7 cells transiently co-expressing myristylation-defective (Myr N ) and protease-defective (PR N ) human immunodeficiency virus (HIV) mutants can release infectious virions when co-transfected with an amphotropic murine leukaemia virus envelope protein expression plasmid (SV-A-MLV-env). In contrast, no infectious virions were detected when a PR N , noninfectious HIV gag mutant was co-expressed with the Myr N mutant, although the Myr N mutant could still process the immature core particles in trans. This result indicates that generation of functionally normal Gag proteins is required for virus infectivity in our complementation system. A mutant with a 56-amino-acid deletion in the N-terminal region of the capsid (CA) domain could still complement the PR N mutant to generate infectious virions, suggesting that the deletion mutant could provide a functional protease for processing in the PR N mutant. This result is consistent with the concept that mutations within the N-terminal region of the CA domain have no major effects on Gag-Pol incorporation into particles.
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The human immunodeficiency virus (HIV) gag gene encodes Gag proteins which self-assemble into virions in the late stages of the virus life cycle. The Gag protein is initially translated as a polyprotein precursor, Pr55 gag . The N terminus of Pr55 gag is co-translationally modified by myristic acid (Towler et al., 1987 ; Wilcox et al., 1987) . Myristylation of HIV Gag proteins is required for membrane association and particle formation (Bryant & Ratner, 1990 ; Pal et al., 1990) . During or after virus budding, Pr55 gag is proteolytically processed by a virus-encoded protease (PR) into p17 (matrix), p24 [capsid Author for correspondence : Chin-Tien Wang.
Fax j886 2 874 2279. e-mail ctwang!vghtpe.gov.tw (CA)], p7 (nucleocapsid) and p6 (Leis et al., 1988 ; Mervis et al., 1988 ; Overton et al., 1989 ; Henderson et al., 1992) . Proteolytic processing of Pr55 gag is essential for virus infectivity (Kohl et al., 1988 ; Gottlinger et al., 1989 ; Peng et al., 1989) . The viral protease derives from the pol gene that is translated as a Pr160 gag -pol by k1 ribosomal frameshifting at a frequency of 5-10 % (Jacks et al., 1988 ; Wilson et al., 1988) . Dimerization of the retroviral PR during virion assembly is a prerequisite for activation of PR and subsequent proteolytic cleavage of Gag and Gag-Pol polyproteins (Le Grice et al., 1988 ; Burstein et al., 1991) . The other cleavage products of HIV Pol are reverse transcriptase (RT), RNaseH and integrase enzymes, which are required for virus replication. Pr160 gag -pol is also myristylated at the N terminus and appears to be incorporated into the assembling virus via its N-terminal Gag determinants. Although the regions responsible for Gag-Pol assembly into virions have not been defined precisely, previous studies coexpressing Pr55 gag and Pr160 gag -pol from separate plasmids have shown that myristylation-defective (Myr − ) Pr160 gag -pol can be incorporated into immature Pr55 gag virus particles (Park & Morrow, 1992 ; Smith et al., 1993) . Since Smith et al. (1993) have demonstrated that transient co-expression of nonmyristylated Pr160 gag -pol and wild-type Pr55 gag could lead to generation of processed mature core particles, it is conceivable that co-expression of these two proteins with an additional envelope protein expression plasmid may result in production of infectious virions.
To test this possibility, we transiently co-transfected COS7 cells with a protease-defective but assembly-competent HIV mutant (PR − or dl.NsiPst PR − ), a Myr − HIV mutant and an amphotropic murine leukaemia virus envelope protein expression plasmid (SV-A-MLV-env) ; infectivity of the released virions was analysed. As described previously (Wang & Barklis, 1993) and shown in Fig. 1 , the PR − construct, which contains a linker insertion within the protease-coding region, inhibits proteolytic processing of virus particles. The Myr − mutant lacks the myristylation signal and prevents virus assembly. The dl.NsiPst PR − mutant was generated by introducing the protease mutation into a HIV gag mutant dl.NsiPst which contains a 56-amino-acid deletion mutation 
NsiI-PstI
NsiI-PstI Fig. 1 . HIV gag mutant constructs. As described previously (Wang & Barklis, 1993) , the Myr − mutant, generated from a mutant provided by L. Ratner (Bryant & Ratner, 1990) , contains a second codon glycine alanine mutation which blocks particle assembly and release ; PR − is a protease mutant with a linker insertion at BclI-2429 ; dl.NsiPst is a capsid mutation with a deletion from NsiI-1251 to PstI-1418. The dl.NsiPst PR − is a double mutant construct generated from recombination of dl.NsiPst and PR − . All HIV mutants were expressed in the HIVgpt backbone which was provided by D. Littman (Page et al., 1990) .
within the CA domain. Previous experiments have shown that the noninfectious dl.NsiPst mutant could still assemble and process particles ; it also exhibited wild-type retrovirus particle density and possessed wild-type RT activity (Wang & Barklis, 1993) . The backbone of our HIV-1 mutant constructs is HIVgpt (Page et al., 1990) , a replication-defective, HIV proviral genome which contains the drug-resistant gene gpt (Mulligan & Berg, 1981) in the env region.
Since proteolytic cleavage of the Gag precursor is a prerequisite for virus infectivity, we first tested whether culture supernatants derived from cells co-expressing the PR − and Myr − mutants contained mature processed core particles. To do this, plasmid DNAs (15 µg) from the wild-type or PR − or Myr − mutants were transfected into COS7 cells by the calcium phosphate precipitation method. For co-transfection, 10 µg of each construct was used. At 48-72 h post-transfection, culture supernatants were collected, filtered through a 0n45-µm-poresize filter, and centrifuged through 2 ml of 20 % sucrose cushion in TSE (10 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, 0n1 mM PMSF) at 4 mC for 40 min at 274 000ig (SW41 rotor at 40 000 r.p.m.). Virus pellets were suspended in IPB (20 mM Tris-HCl pH 7n5, 150 mM NaCl, 1 mM EDTA, 0n1 % SDS, 0n5 % sodium deoxycholate, 1 % Triton X-100, 0n02 % sodium azide) plus 0n1 mM PMSF. Cells were rinsed with ice-cold PBS, collected in IPB plus 0n1 mM PMSF, and then subjected to microcentrifugation at 4 mC for 15 min at 13 700ig (14 000 r.p.m.) to remove debris. Supernatant and cell samples were mixed with an equal volume of 2i sample buffer (12n5 mM Tris-HCl pH 6n8, 2 % SDS, 20 % glycerol, 0n25 % bromophenol blue) and 5 % β-mercaptoethanol and boiled for 4-5 min. Samples were subjected to SDS-PAGE and then to Western immunoblotting. For immunodetection of HIV Gag proteins, a mouse anti-p24 gag monoclonal antibody diluted at 1 : 5000 was used as a primary antibody. The secondary antibody was a goat anti-mouse immunoglobulinalkaline phosphatase conjugate. As shown in Fig. 2 (a) , the mature Gag product p24 and incompletely processed products Pr55 gag and p41 gag were detected in the supernatant and cell samples of wild-type HIVgpt (Fig. 2 a, lanes B and H) . Processed Gag products of Myr − Pr55 gag were observed in cell samples (Fig. 2 a, lane I) but not in the supernatant (Fig. 2 a, lane C) . Expression of the PR − mutant released immature Pr55 gag into the cell medium (Fig. 2 a, lanes D and J) . As expected, coexpression of PR − and Myr − mutants resulted in the appearance of mature core product p24 gag in the medium supernatants (Fig. 2 a, lane E) , suggesting that nonmyristylated Gag-Pol proteins can be assembled into PR − virus particles and provide a functional protease. However, it is possible that the detected p24 gag may derive from the intracellularly processed Gag proteins which were incorporated into assembling PR − particles as the PR − mutant budded from the cell membrane. To test this possibility, we performed another complementation experiment. COS7 cells were either transfected with wild-type, dl.NsiPst, dl.NsiPst PR − or Myr − , or cotransfected with dl.NsiPst PR − plus Myr − . Western immunoblotting analysis showed that cells transfected with dl.NsiPst alone released unprocessed and processed mutant Gag proteins, revealing a band at 49 kDa and bands at 34-36 kDa and 16-20 kDa (Fig. 2 b, lanes B and M) , which is consistent with a deletion of 56 amino acids. Expression of dl.NsiPst PR − in COS7 cells released unprocessed Pr49 gag into the medium (Fig.  2 b, lanes D and K) . Cells co-transfected with both the dl.NsiPst PR − and Myr − mutants released both unprocessed Pr49 gag and the processed Gag products p16 to p20 (Fig. 2 b, lanes C and  L) . However, p24 gag was only detected inside cells transfected either with Myr − alone (Fig. 2 b , lanes E and J) or with Myr − plus dl.NsiPst PR − (Fig. 2 b, lane L) and not seen in the medium supernatants of co-transfectants (Fig. 2 b, lane C) . In contrast, Gag proteins p16 to p20 derived from proteolytic processing of Pr49 gag were observed in the co-transfectant supernatant sample (Fig. 2 b, lane C) but not seen in the cell sample (Fig. 2 b, 
lane L).
These results support our hypothesis that the p24 proteins observed in the co-transfectant culture media are not derived from intracellularly processed Gag proteins but most likely result from proteolytic processing of Pr55 gag by the incorporated nonmyristylated Gag-Pol which provides a functional protease in trans during particle assembly and budding. Previous studies have reported that 90 % of virus-associated Gag proteins can be recovered when centrifuged through a 2 ml 20 % sucrose cushion at 4 mC for 40 min at 274 000ig (Wang & Barklis, 1993) . We believed that our Gag proteins recovered from supernatants should be virus-associated. We performed a sucrose density-gradient fractionation experiment to analyse whether the p24 gag released from cells co-expressing PR − and Myr − was associated with retrovirus particles. Supernatants from COS7 cells co-transfected with PR − and Myr − were centrifuged through linear sucrose gradients (20-60 %). Fractions were collected, measured for density and analysed for Gag proteins by Western immunoblotting. Peak p24 gag fractions banded at densities of 1n14-1n18 g\ml, which is consistent with wild-type retrovirus particle density (data not shown).
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Since co-expression of PR − and Myr − in COS7 cells could produce virions with wild-type retrovirus particle density, we then tested the infectivity of virus particles released from the co-transfectants. To do so, mutant HIVgpt constructs were cotransfected into COS7 cells with SV-A-MLV-env (Page et al., 1990) . At 48-72 h post-transfection, virus-containing supernatants were collected, filtered and used to infect HeLa cells. Adsorption of virions was allowed to proceed at 37 mC in the presence of 4 µg\ml polybrene. Selection of mycophenolicacid-resistant colonies followed the protocol as described previously (Wang & Barklis, 1993) . Colonies were fixed and stained with 50 % methanol plus 0n5 % methylene blue. Numbers of drug-resistant colonies were converted into titres (c.f.u.\ml). Infectivity was determined by the ratio of the mutant titre to the titre of wild-type HIVgpt in parallel experiments. As shown in Table 1 , neither PR − nor Myr − mutants were infectious. However, co-expression of the two noninfectious mutants produced infectious virus particles in three separate experiments. Co-transfection of PR − with dl.NsiPst also resulted in infectious virus particles, indicating that dl.NsiPst Gag-Pol can be assembled into PR − particles and provide a functional protease in trans. This result is consistent with a previous study suggesting that deletion mutations within the N-terminal region of the capsid protein have no major effects on the incorporation of the mutant Pr160 gag -pol into Pr55 gag particles (Srinivasakumar et al., 1995) . Since dl.NsiPst was noninfectious, it was not surprising that its protease-defective counterpart, dl.NsiPst PR − , was also noninfectious (Table 1) despite assembly of the Myr − Gag-Pol into dl.NsiPst PR − particles (Fig. 2 b) . These data suggested that generation of functionally equivalent normal Gag proteins is necessary in our complementation experiments in order to produce infectious virions. In support of this concept, previous studies of HIV gag mutants have suggested that the HIV Gag proteins are functionally involved in the post-assembly and post-processing stages of virus infectivity (Wang & Barklis, 1993) . Although the amount of incorporated Myr − Gag-Pol was not examined in this study, assembly of Myr − Gag-Pol into virions could be determined by detection of proteolytic processing of the assembly-competent Gag precursors. It is unknown whether the Myr − mutant had any effect on viral RNA packaging in our system ; however, a previous study reported that the HIV PR − mutant did not appear to have impaired viral genomic RNA packaging (Wang & Barklis, 1993) . We also cannot exclude the possibility that recombination events may occur during the pre-integration stage. Further experiments are required to examine whether the drugresistant colonies of the infected cells contain any recombinant proviral genome. In our transient co-expression system, however, the generation of infectious virions due to recombination within co-transfected cells was highly unlikely.
CEJJ
In conclusion, we have demonstrated that co-transfection of PR − and Myr − mutants with an amphotropic murine leukaemia virus envelope protein expression plasmid into COS7 cells could produce infectious virions in a single cycle infection assay. Western immunoblot analysis indicates that the Myr − Gag-Pol can be assembled into PR − particles and provide a functional protease in trans. This result supports the notion that the myristylation signal is not absolutely required for HIV Gag-Pol incorporation into virus particles. The fact that the dl.NsiPst can complement PR − in trans to generate infectious virions suggests that the deletion within the Nterminal region of the CA domain has no major effects on Gag-Pol incorporation into PR − particles. One recent study has shown that several domains within HIV pol are involved in particle processing and maturation (Quillent et al., 1996) . Our system of complementation experiments to generate infectious virions may provide a tool to investigate the potential effects of mutant Gag-Pol on the process of virus maturation and infectivity.
